Observational Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Dec 7, 2018; 24(45): 5179-5188
Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5179
Table 1 Baseline patient’s characteristics n (%)
Total number of lesions112
Mean age, years (SD)67.7 (10.1)
Sex ratio, % male57.1
Weight (Kg, SD)74.7 (15.4)
BMI (Kg/m2, SD)27.6 (5.1)
Family History of CRC27 (24.1)
Personal History of CRC7 (6.3)
Current smoking20 (17.9)
Diabetes19 (17.0)
Lesion size, mm (median, interquartile range)20 (14-30)
Categorical size
10-19 mm47 (42.0)
20-39 mm52 (46.4)
≥ 40 mm13 (11.6)
Location of the lesion
Cecum15 (13.4)
Ascending53 (47.3)
Transverse20 (17.9)
Descending4 (3.6)
Sigmoid10 (8.9)
Rectum10 (8.9)
ASA classification
ASA I18 (16.1)
ASA II56 (50.0)
ASA III38 (33.9)
Paris classification
0-Is48 (42.9)
0-IIa50 (44.6)
Other combinations (IIa + Is/IIc)14 (12.5)
NICE classification
NICE I17 (15.2)
NICE II94 (83.9)
NICE III1 (0.9)
Number of resected pieces
2-5 pieces46 (41.1)
> 5 pieces66 (58.9)
Baseline histology
Hyperplastic4 (3.6)
Adenoma with LGD53 (47.3)
Adenoma with HGD39 (34.8)
Sessile serrated adenoma (SSA)11 (9.8)
Traditional serrated adenoma (TSA)2 (1.8)
Adenocarcinoma (pT1 stage)3 (2.7)
Use of clips59 (52.7)
Clips per lesion (median, interquartile range)3 (1-3)
Use of clips
Prophylactic56 (94.9)
Intraprocedural bleeding2 (3.4)
Suspicion of deep mural injury1 (1.7)
Tattooed lesion after EPMR38 (33.9)
Endoscopist who performed piecemeal EMR
Expert endoscopists98 (87.5)
General gastroenterologists14 (12.5)
Median time to review (months, interquartile range)3.9 (3.0-5.3)